Display Settings:

Format

Send to:

Choose Destination
    J Control Release. 2009 Dec 3;140(2):100-7. Epub 2009 Aug 8.

    Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow.

    Source

    Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA. eaf4z@virginia.edu

    Abstract

    To improve ultrasound contrast agents targeted to the adhesion molecules P-selectin and VCAM-1 for the purpose of molecular imaging of atherosclerotic plaques, perfluorocarbon-filled phospholipid microbubble contrast agents were coupled by a polyethylene glycol-biotin-streptavidin bridge with mAb MVCAM.A(429), a sialyl Lewis(x) polymer (PAA-sLe(x)), or both (dual). Approximately three hundred thousand antibody molecules were coupled to the surface of each microbubble. Recombinant mouse P-selectin and/or VCAM-1 coated on flow chambers showed saturation of binding at approximately 15 ng/microl, resulting in 800 and 1200 molecules/microm(2) for P-selectin and VCAM-1, respectively. Dual substrates coated with equal concentrations of P-selectin and VCAM-1 had site densities between 50 and 60% of single substrates. When microbubbles were perfused through flow chambers at 5 x 10(6) microbubbles/ml (wall shear stress from 1.5 to 6 dyn/cm(2)) dual-targeted microbubbles adhered almost twice as efficiently as single-targeted microbubbles at 6 dyn/cm(2). The present study suggests that dual-targeted contrast agents may be useful for atherosclerotic plaque detection at physiologically relevant shear stresses.

    PMID:
    19666063
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2783796
    Free PMC Article

    Images from this publication.See all images (5) Free text

    Figure 4
    Figure 2
    Figure 1
    Figure 5
    Figure 3

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk